...
首页> 外文期刊>Journal of Clinical Pathology >Comparison of renal function markers in Kuwaiti patients with sickle cell disease.
【24h】

Comparison of renal function markers in Kuwaiti patients with sickle cell disease.

机译:科威特镰状细胞病患者肾功能指标的比较。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Proteinuria is a common manifestation of renal disease which is a significant cause of morbidity in patients with sickle cell disease (SCD). OBJECTIVE: To evaluate and compare cystatin C, beta(2)-microglobulin, and creatinine as markers of renal disease in relation to the degree of proteinuria and other complications of SCD. METHODS: 24 h urine collections were used for estimation of urine protein and creatinine clearance in 59 patients with SCD. Results were correlated with plasma cystatin C, beta(2)-microglobulin, creatinine, glomerular filtration rate (GFR; derived from plasma creatinine by Cockcroft-Gault, MDRD formulae, and calculated cystatin C clearance), and clinical and haematological variables. RESULTS: Comparing the different methods of GFR, the proportion of patients with hyperfiltration (GFR >140 ml/min) were 30.5% (MDRD), 44.1% (Cockcroft-Gault), and 10.2 % (calculated cystatin C clearance). Cystatin C was the most consistent marker of hyperfiltration. The endogenous markers of GFR showed an increasing trend with increasing proteinuria, but haematological variables were not correlated with cystatin C, beta(2)-microglobulin, or plasma creatinine. Urine protein excretion was correlated with age (r = 0.33) and significant proteinuria was present in 13.6% of patients. Patients with proteinuria had lower haemoglobin concentration (p = 0.027) than those without proteinuria but HbF was not related to the degree of proteinuria or to markers of GFR. CONCLUSIONS: Markers of GFR show variable ability to identify hyperfiltration in patients with SCD, but cystatin C is the best endogenous marker. Proteinuria is associated with age, haemoglobin, and abnormalities of GFR. Routine screening is recommended to allow for early detection and intervention.
机译:背景:蛋白尿是肾脏疾病的常见表现,是镰状细胞疾病(SCD)患者发病的重要原因。目的:评估和比较半胱氨酸蛋白酶抑制剂C,β(2)-微球蛋白和肌酐作为肾脏疾病的标志物,与蛋白尿程度和SCD的其他并发症有关。方法:24小时尿液收集用于评估59例SCD患者的尿蛋白和肌酐清除率。结果与血浆半胱氨酸蛋白酶抑制剂C,β(2)-微球蛋白,肌酐,肾小球滤过率(GFR;通过Cockcroft-Gault从血浆肌酐中得出,MDRD公式以及计算的胱抑素C清除率)以及临床和血液学变量相关。结果:与不同的GFR方法进行比较,超滤(GFR> 140 ml / min)的患者比例分别为30.5%(MDRD),44.1%(Cockcroft-Gault)和10.2%(计算的半胱氨酸蛋白酶抑制剂清除率)。胱抑素C是超滤的最一致的标志。 GFR的内源性标志物显示随着蛋白尿的增加而增加,但血液学变量与胱抑素C,β(2)-微球蛋白或血浆肌酐无关。尿蛋白排泄与年龄有关(r = 0.33),并且13.6%的患者存在明显的蛋白尿。蛋白尿患者的血红蛋白浓度低于无蛋白尿的患者(p = 0.027),但HbF与蛋白尿程度或GFR标志无关。结论:GFR标记物在SCD患者中识别超滤的能力可变,但是半胱氨酸蛋白酶抑制剂C是最好的内源性标记物。蛋白尿与年龄,血红蛋白和GFR异常有关。建议进行常规筛查,以便及早发现和干预。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号